Is Biotechnology in Your Future?

Despite its humble beginnings in the late 1970s, the biotechnology industry has transformed itself into one of the most vibrant sectors of the American economy. Pharmaceutical companies, once the bell weather of the life sciences industry, have finally conceded that biotechnology and not small molecules are the industry’s future!

While growth of the biotechnology industry has slowed somewhat in the past couple of years—mainly because of the recession—it still represents a viable career option for students interested in the biological sciences. Contrary to popular belief, a PhD degree is no longer required to gain employment in the biotechnology industry. The PhD degree option is slowly being replaced by biotechnology masters and undergraduate degrees and certificate programs readily available at many two year colleges. Put simply, there is a decreasing demand for PhDs at many life sciences companies—mostly because of technological advances and a growing reliance on outsourcing to carry out drug discovery and development. However, the demand for non-PhD employees with solid biotechnology backgrounds particularly in the areas of regulatory affairs, licensing, business development, medical communications, health informatics and biomanufacturing is rising.

For many students (especially high school and undergraduates), the plethora of biotechnology degree and certificate programs can be overwhelming. With this in mind, I came across a cool website called Biotechnology Degree Guide which helps students decide which program is right for them. The site is run by Webster Jorgensen who sent me the following information about the site.

“Biotechnology Degree Guide was developed to be a complete and comprehensive guide for finding colleges, universities and technical schools offering biotech and related programs. The site also features a rating system that allows registered users to rate various biotechnology programs. This feature was added to help separate the great programs from the not-sop-great ones. In the future, we plan to start highlighting "Hidden Gem" programs section that helps schools with lower profiles and great programs receive more exposure. The sites members section is open to prospective students, students, professionals, teachers and biotech hobbyists.  A social media component is planned for the future.”

While the Biotechnology Degree Guide may not answer all of your questions, it certainly is a good place to start when considering a career in biotechnology!

Until next time...

Good Luck and Good Job Hunting!!!!!!!!!!

 

SocialTwist Tell-a-Friend

Can Scientists Be Effective CEOs?

Over the past 30 years or so, the vast majority of chief executives in the drug business have made their way to the top via the sales and marketing departments. Few senior executives have toiled in a research laboratory or for that matter, know the difference between NMR and protein purification. However, things may be changing in the industry. A quick perusal of the CEOs of the top 20 pharmaceutical and biotechnology companies (see below) reveals that 11 of 20 have degrees in engineering (4), medicine (2) and science (5). The remaining 9 have degrees in business and finance (3), sales and marketing (4) or law (2). Several of the scientists (2), engineers (3) and one physician also earned MBA degrees.

 

Conventional wisdom suggests that scientists usually do not make good CEOs (they are not formally trained in business). However, doesn’t the lack of scientific sensibility put non-scientist CEOs at a disadvantage when it comes to making strategic and operational decisions about R &D?  One would think so….!!!!

 

A careful examination of my top 20 list suggests that some of the most successful companies are run by scientist CEOs, e.g. Genentech, Gilead, Novartis and Lilly. Expect to see more scientist CEOs at large biotechnology and pharmaceutical companies in the future–R&D have become way too complex for non-scientist to truly understand its nuances and potential pitfalls. Plus, we scientists know that obtaining a MBA degree is a “piece of cake” as compared with the PhD degree! Hmmm, I wonder what business people think about PhDs?

Company

Name

Background

2006 Total Compensation

Abbott

Miles White

Mechanical Engineering and Business (MBA)

$26,915,358 

Amgen

Kevin Sharer

Aeronautical Engineering and Business (MBA)

$34,390,000

AstraZeneca

David Brennan

Sales and Marketing

$4,226,000 

Biogen/IDEC

James Mullen

Chemical Engineering

$1,450,000

Bristol-Myers Squibb

Jim Cornelius

Business (MBA) and Finance

$1,472,879

Eli Lilly

John Lechleiter

Chemistry (PhD)

Not available (newly appointed)

Genentech

Arthur D. Levinson

Molecular Biology (PhD)

$17,124,025 

Genzyme

Henri A. Termeer

Finance and Business (MBA)

$36,380,000

Gilead

John C. Martinis

Organic Chemistry (PhD), Chemical Engineering and Business (MBA)

$22,860,000

GlaxoSmithKline

JP Garnier

Pharmacology (PhD) and Business (MBA)

$5,413,000 

Johnson & Johnson

William C. Weldon

Sales and Marketing

$28,557,749 

MedImmune

David Mott

Banking and Investment

$11,411,897

Merck

Richard T. Clark

Business and Marketing (MBA)

$10,236,740

Millennium

Deborah Dunsire

Physician (MD)

$3,874,464

Novartis

Daniel Vasella

Physician (MD) and Business (MBA)

3,199,505 CHF

Pfizer

Jeffery Kindler

Lawyer

$9,799,233 

Roche

Severin Schwan

Lawyer and Finance

Not available (newly appointed)

Sanofi Aventis

Gerard Le Fur,

Pharmaceutical Sciences (PhD)

Not available (newly appointed)

Schering Plough

Fred Hassan

Chemical Engineering and Business (MBA)

$5,790,000

Wyeth

Bernard Poussot

Business and Finance

Not available (newly appointed)

Until next time….

Good Luck and Good Job Hunting!!!!!!!!